Top Markets
#1 Islamic Coin Islamic Coin +154.46%
#2 PulseChain PulseChain +48.38%
#3 Ergo Ergo +29.15%
#4 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.40%
#5 RedStone RedStone +16.30%
#6 SkyAI SkyAI +10.37%
#7 Lighter Lighter +9.20%
#8 OPENLOOT OPENLOOT +8.93%
#9 Siren Siren +8.92%
#10 MarsCoin MarsCoin +8.84%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Kedudukan dalam Saham #28170
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Harga Saham
$0.5495
Disegerakkan terakhir: 2025-05-15
Modal Pasaran
$28.14M
Perubahan (1 hari)
4.70%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Enzo Biochem, Inc. (ENZ)

Kategori

Healthcare
Nisbah P/E bagi Enzo Biochem, Inc. (ENZ)
Nisbah P/E pada August 2026 TTM: -0.62
Menurut laporan kewangan dan harga saham terkini Enzo Biochem, Inc., nisbah P/E semasa (TTM) ialah -0.62. Pada akhir 2023, syarikat mempunyai nisbah P/E sebanyak 3.59.
Sejarah nisbah P/E bagi Enzo Biochem, Inc. dari 2000 hingga 2026
Nisbah P/E pada akhir setiap tahun
Tahun Nisbah P/E Ubah
2026 (TTM) -0.62 -72.41%
2024 -2.23 -162.05%
2023 3.59 -168.85%
2022 -5.21 -111.36%
2021 45.87 -1,469.40%
2020 -3.35 78.71%
2019 -1.87 -90.67%
2018 -20.09 -90.00%
2017 -200.84 -3,032.49%
2016 6.85 -111.50%
2015 -59.55 190.81%
2014 -20.48 332.49%
2013 -4.73 219.47%
2012 -1.48 -86.89%
2011 -11.31 43.80%
2010 -7.86 -3.16%
2009 -8.12 -83.50%
2008 -49.20 45.77%
2007 -33.75 27.33%
2006 -26.50 -114.85%
2005 178.44 -370.03%
2004 -66.08 -139.03%
2003 169.30 211.46%
2002 54.36 -45.50%
2001 99.74 -51.07%
2000 203.85 0.00%
Nisbah P/E untuk syarikat serupa atau pesaing
Syarikat Nisbah P/E Perbezaan Nisbah P/E Negara
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 31.59 -5,234.81%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 35.83 -5,923.48%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 -227.89 36,937.17%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 38.69 -6,388.15%
US
Cara membaca nisbah P/E

Nisbah Harga/Perolehan (P/E) mengukur hubungan antara harga saham syarikat dan pendapatan sesaham.
P/E yang rendah tetapi positif menunjukkan syarikat menjana keuntungan tinggi berbanding dengan penilaian semasa dan mungkin dinilai rendah. P/E negatif yang tinggi (hampir 0) menunjukkan kerugian besar.

Syarikat dengan P/E melebihi 30 atau negatif biasanya dilihat sebagai "saham pertumbuhan", bermaksud pelabur menjangkakan pertumbuhan atau keuntungan masa depan.

Syarikat dengan P/E positif di bawah 10 biasanya dianggap sebagai "saham nilai", bermaksud syarikat sudah menguntungkan dan tidak dijangka berkembang pesat.